AptaBio Therapeutics Market Cap

AptaBio Therapeutics has a market cap or net worth of 226.7 billion as of January 16, 2026. Its market cap has increased by 25.12% in one year.

Market Cap

226.70B

Enterprise Value

215.92B

Revenue

3.44B

Ranking

n/a

PE Ratio

n/a

Stock Price

8,120.00

Market Cap Chart

Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 226.70B, a decrease of -46.44%. That is a compound annual growth rate of -9.01%.

Market Cap History

Date	Market Cap	% Change
Jan 19, 2026	226.70B	-13.16%
Dec 30, 2025	261.04B	52.45%
Dec 30, 2024	171.23B	-15.15%
Dec 28, 2023	201.80B	-15.02%
Dec 29, 2022	237.48B	-71.24%
Dec 30, 2021	825.71B	46.50%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Jun 12, 2019	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	90.13T
Celltrion	45.73T
ALTEOGEN	27.70T
ABL Bio	10.89T
SK Biopharmaceuticals	9.43T
Yuhan	8.05T
HLB Co., Ltd.	6.97T
Sam Chun Dang Pharm.	6.49T

Market Cap Rankings